Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Published on: 21 September 2016
Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives
Published on: 14 September 2016
Published on: 19 February 2016
Effect of long-acting erythropoiesis-stimulating agents on hemoglobin levels at the initiation of dialysis
Published on: 22 February 2016
Recent advances in the pathophysiology and management of protein-energy wasting in chronic kidney disease
Published on: 30 January 2016
Published on: 23 February 2016
The 63rd Annual Meeting of the Japanese Society for Dialysis Therapy
28 June - 1 July 2018, Kobe International Conference Center
The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama
The 51st Annual Meeting of the Japanese Society for Clinical Renal Transplantation
February 2018, Kobe Fashion Mart Event Floor
The 23rd Annual Meeting of the Japanese Society for Peritoneal Dialysis
7 - 8 October 2017, Kitakyushu International Conference Center
The 24th Annual Meeting of the Japanese Society for Peritoneal Dialysis
6 - 7 October 2018, Toshi Center Hotel Tokyo
The 28th Annual Meeting of the Japan Society for Blood Purification Critical Care
22 - 24 September 2017, Hotel Rafre Saitama
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.
The Japanese Society for Clinical Renal Transplantation (JSCRT) was founded in 1969 on the vision of promoting the advancement of the science and practice of renal transplantation. JSCRT has expanded to include nearly 1,500 renal transplant professionals, including surgeons, physicians, pediatrician, nurses, coordinators, social workers, pharmacists, and dieticians. JSCRT is also dedicated to educating renal transplant professionals, to promoting research, and to advocating the highest quality care for patients.
The Japanese Society for Peritoneal Dialysis (JSPD) aims to contribute to the advancement of medicine and medical practice, the development of academic culture and people’s welfare through implementing programs for advancement, development and propagation of medical practice and research regarding renal failure and peritoneal dialysis therapies for people all over Japan. JSPD was established in 1995, and has currently 1,500 members.
The Japan Society for Blood Purification in Critical Care was founded in 1990 and aims to further the development and establishment of acute blood purification, such as continuous renal replacement therapy (CRRT). JSBPCC comprises nephrologists, emergency/critical care physicians, as well as clinical engineers and nurses mainly working in intensive care units (ICU). JSBPCC is dedicated to the development of safe and effective blood purification therapy for saving the lives of critically ill patients.
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.